SEC Form 4 · accession 0001162194-16-000244
STANDARD BIOTOOLS INC. · LAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Oct 19, 2016
Accepted (ET)
Oct 21, 2016 · 7:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001162194
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2,F1 | $47.55 | Oct 19, 2016 | D | 65,000 | D | — | Mar 14, 2024 | Common Stock | 65,000 | 0 | D |
| Employee Stock Option (Right to Buy)F2,F3 | $41.14 | Oct 19, 2016 | D | 31,110 | D | — | Mar 12, 2025 | Common Stock | 31,110 | 0 | D |
Explanation of responses
- F11/48th of the shares subject to the Option vested monthly beginning January 1, 2014.
- F2The option was cancelled by mutual agreement of the reporting person and Fluidigm Corporation. As consideration for the cancellation of the options, the reporting person entered into a Separation Agreement and Release that will be filed as Exhibit 99.1 to Fluidigm Corporation's Current Report on Form 8-K on October 24, 2016.
- F31/48th of the shares subject to the Option vested monthly beginning January 1, 2015.